Related Experiment Video
Updated: Jun 4, 2026

10:05
High-throughput Detection Method for Influenza Virus
Published on: February 4, 2012
Screening from the world's largest TCM database against H1N1 virus
Tung-Ti Chang1, Mao-Feng Sun, Hsin-Yi Chen
1Laboratory of Computational and Systems Biology, School of Chinese Medicine, China Medical University, Taichung, 40402, Taiwan.
Journal of Biomolecular Structure & Dynamics
|February 8, 2011
Summary
New antiviral agents are urgently needed due to oseltamivir-resistant swine influenza virus (H1N1). Researchers identified three traditional Chinese medicine derivatives that show high binding affinity to the H1 hemagglutinin binding site, offering a promising new antiviral strategy.
Area of Science:
- Virology
- Drug Discovery
- Computational Chemistry
Background:
- The 2009 H1N1 influenza pandemic underscored the need for effective antiviral therapies.
- Emergence of oseltamivir-resistant influenza strains necessitates the development of novel antiviral agents.
- Inhibiting viral entry via hemagglutinin is a key strategy against influenza.
Purpose of the Study:
- To identify novel antiviral agents targeting the H1 hemagglutinin binding site of the H1N1 virus.
- To analyze traditional Chinese medicine (TCM) derivatives for potential anti-influenza activity.
- To investigate the binding interactions of candidate compounds using molecular dynamics simulations.
Main Methods:
- Screened 20,000 traditional Chinese medicine ingredients against the H1 hemagglutinin sialic acid binding site.
- Utilized docking and molecular dynamics simulations to assess receptor-ligand interactions.
- Performed structure-based calculations to determine binding affinities.
Main Results:
- Identified three TCM derivatives (xylopine_2, rosmaricine_14, rosmaricine_15) with high binding affinities.
- These derivatives exhibit an amine group interacting with Glu83 and a pyridinium group with Asp103.
- Molecular dynamics simulations revealed strong hydrogen bonding with Glu83 and transient interactions with Asp103.
Conclusions:
- The identified TCM derivatives show potential as novel hemagglutinin inhibitors.
- A scaffold based on these derivatives could be optimized for high-affinity binding to both Glu83 and Asp103.
- This research offers a promising direction for developing new antiviral drugs against influenza.

